Marlowe gets muted response to positive update and extended buyback
Full-year sales to meet forecasts Profit seen above consensus £15 million extra share buyback Investors in business services group Marlowe (MRL:AIM) seemed underwhelmed at the company's full-year trading update and news of a further share buyback. The shares, which last September jumped 100p or 42% to 340p on the spin-off of Optima Health (OPT:AIM), only managed a gain of 6p or 1.8% to 334p....
